Protagnosit Therapeutics

Twist in Protagonist story as FDA seeks to rescind breakthrough nod 'based on observed malignancies'
Fierce Biotech
Thu, 04/14/22 - 10:47 am
Protagnosit Therapeutics
rusfertide
FDA
breakthrough designation